SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 307 filers reported holding SEATTLE GENETICS INC in Q4 2018. The put-call ratio across all filers is 1.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $2,884,000 | -42.0% | 14,736 | -49.6% | 0.36% | -49.2% |
| Q2 2020 | $4,970,000 | +43.2% | 29,250 | -2.7% | 0.71% | +19.1% |
| Q1 2020 | $3,470,000 | +1.3% | 30,071 | +0.4% | 0.59% | +13.6% |
| Q4 2019 | $3,424,000 | +0.3% | 29,964 | -25.0% | 0.52% | -8.3% |
| Q3 2019 | $3,413,000 | +31.6% | 39,964 | +6.7% | 0.57% | +25.6% |
| Q2 2019 | $2,593,000 | -5.3% | 37,467 | +0.2% | 0.45% | -10.8% |
| Q1 2019 | $2,739,000 | +61.0% | 37,391 | +24.5% | 0.51% | +47.7% |
| Q4 2018 | $1,701,000 | -26.2% | 30,027 | +0.4% | 0.34% | -14.9% |
| Q3 2018 | $2,306,000 | +17.7% | 29,900 | +1.4% | 0.40% | +12.8% |
| Q2 2018 | $1,959,000 | +26.9% | 29,500 | 0.0% | 0.36% | +31.6% |
| Q1 2018 | $1,544,000 | -2.2% | 29,500 | 0.0% | 0.27% | +14.3% |
| Q4 2017 | $1,578,000 | -1.7% | 29,500 | 0.0% | 0.24% | -1.7% |
| Q3 2017 | $1,605,000 | +5.2% | 29,500 | 0.0% | 0.24% | +10.5% |
| Q2 2017 | $1,526,000 | -37.9% | 29,500 | -24.6% | 0.22% | -32.2% |
| Q1 2017 | $2,458,000 | – | 39,100 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lagoda Investment Management, L.P. | 57,170 | $10,013,000 | 5.39% |
| Boxer Capital, LLC | 400,000 | $70,056,000 | 2.25% |
| PARTNERS CAPITAL INVESTMENT GROUP, LLP | 110,153 | $19,292,000 | 1.10% |
| DCF Advisers, LLC | 13,300 | $2,329,000 | 0.96% |
| XTX MARKETS LLC | 2,418 | $423,000 | 0.87% |
| FAIRFIELD, BUSH & CO. | 15,035 | $2,633,000 | 0.77% |
| Parcion Private Wealth LLC | 4,520 | $792,000 | 0.10% |
| Gulf International Bank (UK) Ltd | 26,091 | $4,569,000 | 0.06% |
| Princeton Portfolio Strategies Group LLC | 1,500 | $263,000 | 0.05% |
| Redpoint Investment Management Pty Ltd | 2,392 | $419,000 | 0.04% |